<em>The Lancet</em> Retracts Cardiac Stem Cell Clinical Trial Paper
The Lancet Retracts Cardiac Stem Cell Clinical Trial Paper
The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.
The Lancet Retracts Cardiac Stem Cell Clinical Trial Paper
The Lancet Retracts Cardiac Stem Cell Clinical Trial Paper

The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.

The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.

Piero Anversa
Journals Retract 13 Papers from Heart Stem Cell Lab
Journals Retract 13 Papers from Heart Stem Cell Lab
Kerry Grens | Dec 14, 2018
It’s the latest fallout from an investigation by Harvard and Brigham and Women’s into work overseen by Piero Anversa.
Heart Cell Therapy Trial Paused After Fraud Allegations
Heart Cell Therapy Trial Paused After Fraud Allegations
Ashley P. Taylor | Oct 30, 2018
A trial to test whether so-called c-kit cardiac stem cells, first reported by Piero Anversa, could help patients with chronic heart failure has been halted in light of suspicion surrounding his work.